Literature DB >> 14750147

Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension.

Marcelo Rudzinski1, Tak-Pan Wong, H Uri Saragovi.   

Abstract

Open angle glaucoma is defined as a progressive and time-dependent death of retinal ganglion cells concomitant with high intraocular pressure, leading to loss of visual field. Because neurotrophins are a family of growth factors that support neuronal survival, we hypothesized that quantitative and qualitative changes in neurotrophins or their receptors may take place early in ocular hypertension, preceding extensive cell death and clinical features of glaucoma. We present molecular, biochemical, and phenotypic evidence that significant neurotrophic changes occur in retina, which correlate temporally with retinal ganglion cell death. After 7 days of ocular hypertension there is a transient up-regulation of retinal NGF, while its receptor TrkA is up-regulated in a sustained fashion in retinal neurons. After 28 days of ocular hypertension there is sustained up-regulation of retinal BDNF, but its receptor TrkB remains unchanged. Throughout, NT-3 levels remain unchanged but there is an early and sustained increase of its receptor TrkC in Müller cells but not in retinal ganglion cells. These newly synthesized glial TrkC receptors are truncated, kinase-dead isoforms. Expression of retinal p75 also increases late at day 28. Asymmetric up-regulation of neurotrophins and neurotrophin receptors may preclude efficient neurotrophic rescue of RGCs from apoptosis. A possible rationale for therapeutic intervention with Trk receptor agonists and p75 receptor antagonists is proposed. Copyright 2003 Wiley Periodicals, Inc. J Neurobiol 58: 341-354, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14750147     DOI: 10.1002/neu.10293

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  39 in total

1.  Expression and cell localization of brain-derived neurotrophic factor and TrkB during zebrafish retinal development.

Authors:  A Germanà; C Sánchez-Ramos; M C Guerrera; M G Calavia; M Navarro; R Zichichi; O García-Suárez; P Pérez-Piñera; Jose A Vega
Journal:  J Anat       Date:  2010-07-21       Impact factor: 2.610

2.  A comparative study on the transplantation of different concentrations of human umbilical mesenchymal cells into diabetic rats.

Authors:  Jia-Hui Kong; Dan Zheng; Song Chen; Hong-Tao Duan; Yue-Xin Wang; Meng Dong; Jian Song
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies.

Authors:  Natalie D Bull; Thomas V Johnson; Guncha Welsapar; Nicholas W DeKorver; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

Review 4.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

5.  In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death.

Authors:  Yujing Bai; ZhiHua Shi; Yehong Zhuo; Jing Liu; Andrey Malakhov; Eunhwa Ko; Kevin Burgess; Henry Schaefer; Pedro F Esteban; Lino Tessarollo; H Uri Saragovi
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

6.  NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.

Authors:  Maria Luisa Rocco; Bijorn Omar Balzamino; Graziana Esposito; Carla Petrella; Luigi Aloe; Alessandra Micera
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-24       Impact factor: 3.117

Review 7.  Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Authors:  Brian J Song; Lloyd Paul Aiello; Louis R Pasquale
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 8.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

9.  Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma.

Authors:  Francesca Pasutto; Tomoya Matsumoto; Christian Y Mardin; Heinrich Sticht; Johann H Brandstätter; Karin Michels-Rautenstrauss; Nicole Weisschuh; Eugen Gramer; Wishal D Ramdas; Leonieke M E van Koolwijk; Caroline C W Klaver; Johannes R Vingerling; Bernhard H F Weber; Friedrich E Kruse; Bernd Rautenstrauss; Yves-Alain Barde; André Reis
Journal:  Am J Hum Genet       Date:  2009-09-17       Impact factor: 11.025

10.  Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.

Authors:  ZhiHua Shi; Marcelo Rudzinski; Karen Meerovitch; Frédéric Lebrun-Julien; Elena Birman; Adriana Di Polo; H Uri Saragovi
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.